No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
CRSP241220C44000
- 1.10
- -2.90-72.50%
15min DelayClose Dec 13 16:00 ET
1.55High0.85Low
1.53Open4.00Pre Close135 Volume101 Open Interest44.00Strike Price13.96KTurnover62.83%IV3.02%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry1.10Extrinsic Value100Contract SizeAmericanOptions Type0.4874Delta0.1333Gamma39.80Leverage Ratio-0.1496Theta0.0024Rho19.40Eff Leverage0.0190Vega
Intraday
- 5D
- Daily
News
Piper Sandler Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $105
3 Things You Need to Know If You Buy CRISPR Therapeutics Today
Is CRISPR Therapeutics AG (CRSP) the Worst ARK Stock to Buy According to Short Sellers?
Chardan Capital Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $94
Evercore Maintains CRISPR Therapeutics(CRSP.US) With Hold Rating, Maintains Target Price $60
Crispr Therapeutics AG (CRSP) Gets a Hold From Evercore ISI